How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
Long-term treatment with angiotensin-converting enzyme inhibitors reduces post-infarction morbidity and mortality in patients with left ventricular (LV) systolic dysfunction or symptomatic heart failure. Until recently, the effect of such treatment in patients with preserved LV function has not been...
Na minha lista:
| Publicado no: | Curr Control Trials Cardiovasc Med |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59642/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806788/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-4-151 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|